Table 3:
Epilepsy-related outcomes and health-care utilisation in the 2 years after an initial diagnosis
| Median (IQR) | Mean | p value | |||
|---|---|---|---|---|---|
| Boston Children’s Hospital | IBM MarketScan | Boston Children’s Hospital | IBM MarketScan | ||
| Presence of a diagnosis of status epilepticus* | 0 (0–0) | 0 (0–0) | 0·14 (0·35) | 0·25 (0·43) | <0·0001 |
| Number of inpatient admissions for all causes | 0 (0–0) | 0 (0–0) | 1·57 (7·84) | 0·91 (2·07) | <0·0001 |
| Number of inpatient admissions for seizures | 0 (0–0) | 0 (0–0) | 0·37 (1·25) | 0·34 (0·84) | 0·013 |
| General utilisation; number of distinct days with ICD code | 7 (3–15) | 17 (14–37) | 12·82 (19·89) | 25·78 (37·78) | <0·0001 |
| Seizure-related utilisation; number of distinct days with seizure-related ICD codes | 2 (0–6) | 3 (2–10) | 4·13 (5·97) | 6·40 (14·02) | <0·0001 |
| Number of ASM classes (mean of those receiving at least 1 ASM) | 1 (0–2) | 1 (0–2) | 1·36 (1·79) | 1·41 (1·71) | 0·17 |
| Number of neurology notes during epilepsy-related ICD visit | 3 (1–8) | NA | 6·61 (10·90) | NA | NA |
| Number of seizure-related imaging and procedures | 0 (0–1) | 0 (0–1) | 0·84 (2·35) | 0·86 (2·41) | >0·25 |
| Composite score (meeting any of the criteria defined in panel) | 1 (0–1) | 1 (0–1) | 0·57 (0·50) | 0·63 (0·48) | <0·001 |
Data are median (IQR) or mean (SD). ICD=International Classification of Diseases. ASM=antiseizure medication. NA=not available.
1=present, 0=absent; mean represents proportion of patients with diagnosis.